We are live on ! Find out more
CVS icon

CVS Health

1,779 hedge funds and large institutions have $69.2B invested in CVS Health in 2018 Q4 according to their latest regulatory filings, with 300 funds opening new positions, 896 increasing their positions, 486 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

194% more first-time investments, than exits

New positions opened: 300 | Existing positions closed: 102

84% more repeat investments, than reductions

Existing positions increased: 896 | Existing positions reduced: 486

46% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $775M

11% more funds holding

Funds holding: 1,5991,779 (+180)

5% more funds holding in top 10

Funds holding in top 10: 7983 (+4)

1% more capital invested

Capital invested by funds: $68.8B → $69.2B (+$379M)

3.78% less ownership

Funds ownership: 85.94%82.16% (-3.8%)

Holders
1,779
Holders Change
+180
Holders Change %
+11.26%
% of All Funds
39.64%
Holding in Top 10
83
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+5.06%
% of All Funds
1.85%
New
300
Increased
896
Reduced
486
Closed
102
Calls
$1.13B
Puts
$775M
Net Calls
+$359M
Net Calls Change
+$126M
Name Holding Trade Value Shares
Change
Change in
Stake
PT
826
Plimoth Trust
Massachusetts
$2.07M -$42.8K -574 -2%
WAM
827
Weatherly Asset Management
California
$2.05M -$99.4K -1,332 -4%
ECM
828
Exchange Capital Management
Michigan
$2.05M -$38.2K -512 -2%
TA
829
Townsend & Associates
Colorado
$2.05M +$44.8K +600 +2%
EFIC
830
Eliot Finkel Investment Counsel
California
$2.04M -$36.9K -494 -2%
DRS
831
Deane Retirement Strategies
Louisiana
$2.02M +$7.84K +105 +0.3%
KJHP
832
K.J. Harrison & Partners
Ontario, Canada
$2.02M +$894K +11,983 +64%
AF
833
Alerus Financial
North Dakota
$2.01M -$96.4K -1,291 -4%
ANTB
834
AMG National Trust Bank
Colorado
$2M +$279K +3,743 +14%
HAM
835
Highstreet Asset Management
Ontario, Canada
$1.99M +$969K +12,984 +74%
11A
836
10-15 Associates
New York
$1.99M +$104K +1,396 +5%
ASN
837
Advisory Services Network
Georgia
$1.98M +$206K +2,757 +10%
SIM
838
Sentry Investment Management
Wisconsin
$1.98M +$1.58M +21,181 +236%
VSWA
839
Vontobel Swiss Wealth Advisors
Switzerland
$1.97M -$36.2K -485 -2%
MWM
840
Marietta Wealth Management
Georgia
$1.96M +$186K +2,495 +9%
AWA
841
Artemis Wealth Advisors
New York
$1.94M +$2.22M +29,680 New
HVIA
842
Hudson Valley Investment Advisors
New York
$1.94M -$554K -7,420 -20%
DBT
843
Dubuque Bank & Trust
Iowa
$1.93M +$1.76M +23,611 +402%
SNT
844
Security National Trust
West Virginia
$1.93M -$44.9K -601 -2%
EAM
845
Erste Asset Management
Austria
$1.93M +$2.21M +29,543 New
GIC
846
Gantzert Investment Company
Illinois
$1.92M +$2.19M +29,340 New
PCTC
847
Perkins Coie Trust Company
Washington
$1.92M +$1.64K +22 +0.1%
CWM
848
Concentric Wealth Management
California
$1.9M +$92.6K +1,240 +4%
TCOO
849
Trust Company of Oklahoma
Oklahoma
$1.9M +$123K +1,651 +6%
CHC
850
City Holding Co
West Virginia
$1.89M +$198K +2,649 +10%

CVS Hedge Fund Activity: Q4 2018 in Review

1,779 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2018, worth a combined $69.2B — up 0.55% from $68.8B a quarter earlier.

Buyers outnumbered sellers: 300 funds opened new CVS positions and 102 closed out — a net gain of 198 holders — while 896 added to existing stakes and 486 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.82B. The largest seller was American International Group, cutting an estimated $433M.

  • 1,779 institutional investors held CVS Health (CVS) as of Q4 2018, up from 1,599 in Q3 2018.
  • Funds reported $69.2B of CVS Health stock for Q4 2018, up 0.55% quarter-over-quarter.
  • 300 funds opened new CVS Health positions in Q4 2018 and 102 closed out, a net change of +198 holders.
  • The largest CVS Health buyer in Q4 2018 was Vanguard Group, an estimated $1.82B added.
  • The largest CVS Health seller in Q4 2018 was American International Group, an estimated $433M sold.

Based on aggregated 13F filings for Q4 2018.